TrademarkDir
CYB
LIVE

Serial Number

79340598

Owner

Cybin Corp.

Attorney

Kimberly Bullock Gatling

Filing Date

Mar 1, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYB Trademark

Serial Number: 79340598 • Registration: 7393810

CYB is a trademark filed by Cybin Corp. on March 1, 2022. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Cybin Corp. (19 trademarks)

5600-100 King Street West

Entity Type: 03

Trademark Details

Filing Date

March 1, 2022

Registration Date

May 28, 2024

Published for Opposition

March 12, 2024

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders

Pharmaceutical drug development services

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Jun 20, 2025 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 8, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 22, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 22, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 28, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 28, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 28, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Mar 11, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 21, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2024 CRFA
ASSIGNED TO LIE
Feb 7, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 18, 2023 ERSI
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Sep 12, 2023 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Aug 27, 2023 CRCV
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 14, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 14, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 14, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 6, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 9, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 8, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 13, 2022 CNRT
NON-FINAL ACTION WRITTEN
Dec 13, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
May 24, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2022 REPR

Related Trademarks

More from this Owner

H logo

H

H logo

H

HELUS PHARMA

HELUS PHARMA

HELUS NEUROSCIENCE

HELUS NEUROSCIENCE

HELUS THERAPEUTICS

HELUS THERAPEUTICS

CYBIN

CYBIN